Finance

Lists
532300:BOM
Wockhardt Ltd
₹2,034.70
+0.16%
(+3.15) 1D
Nov 11, 3:53:55 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532300...
Open
₹2,057.15
High
₹2,070.70
Low
₹2,013.85
Mkt. cap
331.73B
Avg. vol.
55.22K
Volume
38.10K
P/E ratio
80.70
52-wk high
₹2,420.00
52-wk low
₹1,086.80
EPS
₹25.21
Shares outstanding
110.69M
No. of employees
3K
Open
₹2,057.15
High
₹2,070.70
Low
₹2,013.85
Mkt. cap
331.73B
Avg. vol.
55.22K
Volume
38.10K
P/E ratio
80.70
52-wk high
₹2,420.00
52-wk low
₹1,086.80
EPS
₹25.21
Shares outstanding
110.69M
No. of employees
3K
News stories
From web sources and news partners
Profile
Wockhardt Limited is an Indian pharmaceutical and biotechnology company headquartered in Mumbai. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company has manufacturing plants in India, the UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. Wikipedia
About Wockhardt Ltd
CEOMurtaza Khorakiwala
Employees2.56K
Founded1967
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
8.88B
10.54B
9.29B
9.69B
Cost of goods sold
3.17B
4.03B
3.20B
3.41B
Cost of revenue
3.17B
4.03B
3.20B
3.41B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.81B
1.90B
2.03B
2.01B
Operating expense
4.63B
4.19B
4.76B
5.19B
Total operating expenses
7.80B
8.22B
7.96B
8.60B
Operating income
1.08B
2.32B
1.33B
1.09B
Other non operating income
250.00M
-710.00M
310.00M
110.00M
EBT including unusual items
670.00M
1.89B
1.16B
730.00M
EBT excluding unusual items
770.00M
1.52B
1.16B
730.00M
Income tax expense
60.00M
250.00M
90.00M
-
Effective tax rate
8.96%
13.23%
7.76%
-
Other operating expenses
2.17B
1.76B
2.18B
2.63B
Net income
590.00M
1.66B
1.06B
790.00M
Net profit margin
6.64%
15.75%
11.41%
8.15%
Earnings per share
-
-
-
-
Interest and investment income
-
70.00M
-
-
Interest expense
-600.00M
-450.00M
-520.00M
-560.00M
Net interest expenses
-600.00M
-380.00M
-520.00M
-560.00M
Depreciation and amortization charges
650.00M
530.00M
550.00M
550.00M
EBITDA
1.47B
2.74B
1.74B
1.64B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps